Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
Wenchao Lu, Shihan Wang, Huilin Tang, et al.
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access | Times Cited: 1
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
Samantha B. Shapiro, Hui Yin, Oriana Hoi Yun Yu, et al.
BMJ (2025), pp. e080679-e080679
Closed Access | Times Cited: 1
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach
Davide Arillotta, Giuseppe Floresta, Guy Pelletier, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 617-617
Open Access | Times Cited: 11
Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study
Isabel Hurtado, Celia Robles, Salvador Peiró, et al.
Diabetologia (2024) Vol. 67, Iss. 11, pp. 2471-2480
Open Access | Times Cited: 8
Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
Michael Nakhla, Ambica Nair, Prachi Balani, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 5
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Measures of Suicidality A Systematic Review
K.L. Valentino, Kayla M. Teopiz, William W. L. Cheung, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 112-126
Open Access
Risk of depression and dementia among individuals treated with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists
Osvaldo P. Almeida
Current Opinion in Psychiatry (2025)
Closed Access
The effect of GLP-1RAs on mental health and psychotropics-induced metabolic disorders: A systematic review
Sigrid Breit, Daniela Hubl
Psychoneuroendocrinology (2025), pp. 107415-107415
Closed Access
GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review
Robertas Strumila, Aistė Lengvenytė, Sebastien Guillaume, et al.
European Neuropsychopharmacology (2024) Vol. 87, pp. 29-34
Open Access | Times Cited: 4
Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
Xu He, Wei Zhao, Ping Li, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Association of GLP‐1 Receptor Agonists With Risk of Suicidal Ideation and Behaviour: A Systematic Review and Meta‐Analysis
Ganesh Bushi, Mahalaqua Nazli Khatib, Shivam Rohilla, et al.
Diabetes/Metabolism Research and Reviews (2025) Vol. 41, Iss. 2
Open Access
GLP-1 Receptor Agonist Exposures Are Increasingly Common and Generally Associated with Mild Symptoms: A Single Poison Center Experience
Stacy Marshall, Erin Ryan, Jessica Rivera, et al.
Journal of Medical Toxicology (2024) Vol. 20, Iss. 3, pp. 278-285
Open Access | Times Cited: 3
Pharmacotherapy of obesity: State of the art and perspectives
Katarina Sićović, Ana Micov
Arhiv za farmaciju (2024) Vol. 74, Iss. 3, pp. 460-482
Open Access | Times Cited: 1
Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study
Yingjie Zhao, Fei Lu, Yongtao Duan
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 135, pp. 111128-111128
Closed Access | Times Cited: 1
A systematic review in effects of glucagon-like peptide-1 (GLP-1) mono-agonists on functional connectivity: Target engagement and rationale for the development in mental disorders
Hezekiah Au, Yang Jing Zheng, Gia Han Le, et al.
Journal of Affective Disorders (2024) Vol. 370, pp. 321-327
Closed Access
Evidence and Mechanism of Bile Acid-Mediated Gut-Brain Axis in Anxiety and Depression
Sydney O Idahosa, Rokia Diarra, H Ranu, et al.
American Journal Of Pathology (2024)
Closed Access
As consequências clínicas do uso de Ozempic no combate à obesidade: uma revisão
Maria Eduarda Diógenes de Freitas Queiroz, Milena Nunes Alves de Sousa
STUDIES IN HEALTH SCIENCES (2024) Vol. 5, Iss. 4, pp. e11497-e11497
Open Access
Page 1

Scroll to top